Ademetionine 1,4-Butanedisulfonate
2025-ZX068
Phase 2 small_molecule active
Quick answer
Ademetionine 1,4-Butanedisulfonate for Obstructive Hypertrophic Cardiomyopathy (oHCM) is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Obstructive Hypertrophic Cardiomyopathy (oHCM)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active